Boston, Massachusetts-based health startup ZappRx scored a further $1 million in funding to streamline the prescription process for patients with pulmonary arterial hypertension (PAH) by becoming their electronic link to the pharmacy.
Breaking News
ZappRx, a mobile platform that automates the prescription management process, has nabbed an additional funding worth $1 million for its seed financing round led by Atlas Ventures.
Pharmaceutical platform startup ZappRX received USD1 million in a recent seed funding.
Subscribe to VCpost newsletter
Most Popular
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Trump Media’s First Auditor Quits After Just a Few Months on the Job: Report
- Tesla Spends $200,000 in Promoting Elon Musk's Social Media Platform X Following Mention of 'Minimal Advertising Efforts'
- UPDATE: Google Employees Arrested and Fired After Staging Protests Over Company's Project Nimbus Deal With Israel
- US Plans to Lift Tariff Exceptions to Dominant Chinese Solar Panel Imports as Biden Accuses Beijing of 'Cheating' on Its Steel Trade Pactices
- Social Security Benefits: 2025 COLA Predicted to Increase Amid Rising Inflation
- Governors in 6 Southern States Warn Workers Against Joining UAW Union, Say Unionization Places Jobs in Jeopardy
- American Airlines Pilots Union Issues Urgent Safety Alert Over Maintenance Issues